GB Patent

GB2206880B — Optical isomers of an imidazole derivative

Assigned to Farmos Yhtyma Oy · Expires 1991-04-24 · 35y expired

What this patent protects

The separated d and l enantiomers of medetomidine and their salts are selective and potent alpha 2-receptor agonists.

USPTO Abstract

The separated d and l enantiomers of medetomidine and their salts are selective and potent alpha 2-receptor agonists.

Drugs covered by this patent

Patent Metadata

Patent number: GB2206880B
Jurisdiction: GB
Classification: —
Expires: 1991-04-24
Drug substance claim: No
Drug product claim: No
Assignee: Farmos Yhtyma Oy
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.